Medicine
Volume 36, Issue 7 , Pages 344-349 , July 2008

Receptor functions

References 

  1. Rang HP, Dale MM, Ritter JM, Flower R. Pharmacology. Chapter 3 6th edn,. London: Churchill Livingstone; 2007;
  2. Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman’s the pharmacological basis of therapeutics. Chapter 2 New York: McGraw Hill Press; 2006;
  3. Lefkowitz RJ. G-proteins in medicine. N Engl J Med. 1995;332:186–187
  4. Lerner MR. Tools for investigating functional interactions between ligands and G-protein coupled receptors. TiNS. 1994;17:142–146
  5. Gilchrist A. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics. Trends Pharmacol Sci. 2007;28:431–437
  6. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835–839
  7. Black JV, Stanley NP. Inverse agonists exposed. Nature. 1995;374:214–215
  8. Vilardaga JP, Steinmeyer R, Harms GS, Lohse MJ. Molecular basis of inverse agonism in a G protein-coupled receptor. Nat Chem Biol. 2005;1:25–28
  9. Colquhoun D. Binding, gating, affinity and efficacy. Br J Pharmacol. 1998;125:923–947
  10. Bleicher KH, Böhm HJ, Müller K, Alanine AI. A guide to drug discovery: hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2003;2:369–378
  11. Wilson S, Bergsma DJ, Chambers JK, et al. Orphan G-protein-coupled receptors: the next generation of drug targets?. Br J Pharmacol. 1998;125:1387–1392

PII: S1357-3039(08)00113-8

doi: 10.1016/j.mpmed.2008.04.004

Medicine
Volume 36, Issue 7 , Pages 344-349 , July 2008

Article Tools

* Image Usage & Resolution